Aberrant Alternative Splicing in Melanoma: Implications for Therapy Resistance
The following is a summary of “Roles and mechanisms of aberrant alternative splicing in melanoma...
Read MoreApr 10, 2024
The following is a summary of “Roles and mechanisms of aberrant alternative splicing in melanoma...
Read MoreApr 9, 2024
1. The pathological response rate had an OR of 3.16 when comparing neoadjuvant dual vs single...
Read MoreApr 5, 2024
The following is a summary of “Histopathologic regression in patients with primary cutaneous...
Read MoreApr 3, 2024
The following is a summary of “Association between weight loss and death in patients with...
Read MoreApr 3, 2024
1. 18-month recurrence-free survival was significantly greater in the combination therapy group...
Read MoreApr 1, 2024
The following is a summary of “Periocular and ocular surface nonmelanoma skin cancer,”...
Read MoreMar 28, 2024
The following is a summary of “Understanding choroidal nevus risk factors for transformation...
Read MoreMar 27, 2024
The following is a summary of “Conjunctival melanoma: Insights into classification,...
Read MoreMar 22, 2024
The following is a summary of “Iris melanoma: Review of clinical features, risks, management, and outcomes,” published in the February 2024 issue of Dermatology by Cherkas, et al. Primary uveal melanoma is a rare...
Read MoreMar 21, 2024
This diagnostic study investigates the performance of a privacy-preserving federated learning approach vs a classical centralized and ensemble learning approach.
Read MoreMar 11, 2024
To describe the first use of high-dose-rate yttrium-90 disc brachytherapy for choroidal melanoma. A 72-year-old patient had a cT1-category choroidal melanoma characterized by the presence of orange pigment, increasing subretinal...
Read MoreMar 7, 2024
In industrialized countries, the aging population is steadily rising. The incidence of cutaneous malignant melanoma (CMM) is highest in old people. This study focuses on the clinicopathological profile of CMM and indicators of...
Read MoreFeb 28, 2024
TUESDAY, Feb. 27, 2024 (HealthDay News) — Delays in melanoma diagnoses due to COVID-19...
Read MoreFeb 23, 2024
The following is a summary of “Melanoma Biology and Treatment: A Review of Novel Regulated Cell...
Read MoreFeb 22, 2024
The following is a summary of “An Update and Review of Clinical Outcomes Using...
Read MoreFeb 21, 2024
TUESDAY, Feb. 20, 2024 (HealthDay News) — Amtagvi (lifileucel) has been approved by the U.S....
Read MoreFeb 20, 2024
The following is a summary of “Melanoma clinicopathological groups characterized and...
Read MoreFeb 19, 2024
Most of the rapid increase in cutaneous melanoma incidence in the US has been localized disease that is treated surgically and is associated with high survival rates. However, little is known about the psychological well-being...
Read MoreFeb 14, 2024
The following is a summary of “Role of Sleep Apnea and Long-Term CPAP Treatment in the Prognosis...
Read MoreFeb 13, 2024
MONDAY, Feb. 12, 2024 (HealthDay News) — For patients with clinical stage I and II melanoma,...
Read MoreSed vitae nulla id ipsum molestie scelerisque vitae vitae ligula. Fusce a massa tortor.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.